TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive Guest Editorial: Nobel Laureates Offer Simple Formula To Save CPRIT From “Infamy and Irrelevance” October 19, 2012
TCL Archive In Brief: Foundation Gives Georgetown $2.9 Million For Pediatric Lab, To Be Headed By Cairo February 6, 1998
TCL Archive IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover July 25, 2014